MD Anderson Research Highlights for February 23, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current findings include targeted therapies for tumors with PIK3CA and FGFR mutations, a promising combination therapy for myelofibrosis, a new target to improve immunotherapy response in pancreatic cancer, a novel method of increasing...
MD Anderson receives over $31 million in CPRIT funding
The University of Texas MD Anderson Cancer Center was awarded $31.73 million from the Cancer Prevention and Research Institute of Texas (CPRIT...
MD Anderson Research Highlights for February 9, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
MD Anderson honors World Cancer Day, reinforces commitment to cancer care, prevention, research and education
The University of Texas MD Anderson Cancer Center celebrates World Cancer Day, Feb. 4, in honor of the global initiative to end cancer.
World Cancer Day is organized by the Union for International Cancer Control (UICC), a partnership comprising more than 1,100 organizations from more than 170 countries. Created in 2000, World Cancer Day raises awareness for cancer issues and showcases efforts from individuals, communities, organizations...
